Context-specific miRNA regulation network predicts cancer prognosis
暂无分享,去创建一个
Changning Liu | Jianghui Xiong | Simon Rayner | Juan Liu | Jingfang Ju | J. Xiong | S. Rayner | Yinghui Li | Shanguang Chen | Changning Liu | J. Ju | Xionghui Zhou | Juan Liu | Xionghui Zhou | Shanguang Chen | Fengji Liang | Yinghui Li | Fengji Liang
[1] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[2] M. Takeichi,et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.
[3] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[4] J. Bergh,et al. Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series , 2007, Clinical Cancer Research.
[5] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Reinders,et al. Module-Based Outcome Prediction Using Breast Cancer Compendia , 2007, PloS one.
[7] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[8] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[9] Yves A. Lussier,et al. ExprTarget: An Integrative Approach to Predicting Human MicroRNA Targets , 2010, PloS one.
[10] David Warde-Farley,et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.
[11] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[12] C. Ulrich,et al. Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[14] R. Shamir,et al. Towards computational prediction of microRNA function and activity , 2010, Nucleic acids research.
[15] Fidel Ramírez,et al. Computing topological parameters of biological networks , 2008, Bioinform..
[16] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[17] E. Miska,et al. MicroRNA—implications for cancer , 2007, Virchows Archiv.
[18] Moshe Oren,et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.
[19] Thomas D. Schmittgen,et al. Regulation of microRNA processing in development, differentiation and cancer , 2008, Journal of cellular and molecular medicine.
[20] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[21] D. Bartel,et al. MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.
[22] Fazlul H. Sarkar,et al. Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research , 2010, Pharmaceutical Research.
[23] Chao Cheng,et al. Inferring MicroRNA Activities by Combining Gene Expression with MicroRNA Target Prediction , 2008, PloS one.
[24] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] N. Miller,et al. O-7 Micro-RNA expression profiling in primary breast tumours , 2007 .
[26] J. Xiong,et al. Pre-Clinical Drug Prioritization via Prognosis-Guided Genetic Interaction Networks , 2010, PloS one.
[27] Yun Xiao,et al. MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features , 2010, Nucleic acids research.
[28] Elda Rossi,et al. Identification of microRNA activity by Targets' Reverse EXpression , 2009, Bioinform..
[29] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[30] John Calvin Reed,et al. Prognostic significance of apoptosis regulators in breast cancer. , 1999, Endocrine-related cancer.
[31] Q. Cui,et al. Identification of high-quality cancer prognostic markers and metastasis network modules , 2010, Nature communications.
[32] G. Kong,et al. miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8* , 2011, The Journal of Biological Chemistry.
[33] Anton J. Enright,et al. MicroRNA targets in Drosophila , 2003, Genome Biology.
[34] Israel Steinfeld,et al. miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors , 2011, PloS one.
[35] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[36] Yvonne Tay,et al. A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.
[37] E. Olson,et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.
[38] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[39] Justin Zobel,et al. Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context , 2010, BMC Bioinformatics.
[40] J. Lieberman,et al. miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases , 2009, PloS one.
[41] M. Peter,et al. Targeting of mRNAs by multiple miRNAs: the next step , 2010, Oncogene.
[42] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[43] George A. Calin,et al. MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.
[44] Karl T Kelsey,et al. MicroRNA responses to cellular stress. , 2006, Cancer research.
[45] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.